Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: Results of a study among 1507 rheumatologists

Annals of the Rheumatic Diseases

Volumn 67, Issue 6, 2008, Pages 782-788

  Gossec, L ^a,b   Dougados, M ^a   Phillips, C ^b   Hammoudeh, M ^c   De Vlam, K ^d   Pavelka, K ^e   Pham, T ^f   Braun, J ^g   Sieper, J ^b   Olivieri, I ^h,i   Van Der Heijde, D ^j   Collantes, E ^k   Stone, M ^l,m   Kvien, T K ⁿ  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Wyeth Europa ^*

^c HAMAD MEDICAL CORPORATION   (Qatar)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e CHARLES UNIVERSITY   (Czech Republic)

^f HÔPITAL DE LA CONCEPTION   (France)

^g RHEUMAZENTRUM RUHRGEBIET   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ Ospedale Civile di Matera   (Italy)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^l UNIVERSITY OF BATH   (United Kingdom)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ DIAKONHJEMMET HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; FEMALE; FUNDING; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOLOGY; SELF REPORT; STATISTICAL ANALYSIS;

ADULT; CONSENSUS; EUROPE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RHEUMATOLOGY; SPONDYLITIS, ANKYLOSING;

EID: 45149106121     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.080077     Document Type: Article

References (13)

1. Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, et al. "Assessment in AS" international working group; European League Against Rheumatism. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006;65:442-52.
2. Grimshaw J, McAuley LM, Bero LA, Grilli R, Oxman AD, Ramsay C, et al. Systematic reviews of the effectiveness of quality improvement strategies and programmes. Qual Saf Health Care 2003;12:298-303.
3. Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J, et al. EULAR. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 2004;63:1172-6.
4. Kosecoff J, Kanouse DE, Rogers WH, McCloskey L, Winslow CM, Brook RH. Effects of the national Institutes of Health Consensus Development Program on physician practice. JAMA 1987;258:2708-13.
5. Grimshaw J, Eccles M, Tetroe J. Implementing clinical guidelines: current evidence and future implications. J Contin Educ Health Prof 2004;24:S31-7.
6. Grol R. Implementation of evidence and guidelines in clinical practice: a new field of research? Int J Qual Health Care 2000;12:455-6.
7. Jamtvedt G, Young JM, Kristoffersen DT, Thomson O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2003;2:CD000259.
8. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ 1998;317:465-8.
9. Martens JD, Winkens RA, van der Weijden T, de Bruyn D, Severens JL. Does a joint development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a pre/post study with concurrent control group and a randomised trial. BMC Health Serv Res 2006;6:145.
10. Grol R. Development of guidelines for general practice care. Br J Gen Pract 1993;43:146-51.
11. Grol R, Wensing M, Eccles M. Improving patient care; the implementation of change in clinical practice. London: Elsevier, 2005.
12. Grimshaw JM, Russell IT. Achieving health gain through clinical guidelines. II: Ensuring guidelines change medical practice. Qual Health Care 1994;3:45-52.
13. Hjardem E, Hetland ML, Ostergaard M, Krogh NS, Kvien TK. Danish Database for Biological Therapies in Rheumatology Study Group. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent. Ann Rheum Dis 2005;64:1220-3.